Literature DB >> 24928629

Protective effects of chelerythrine against lipopolysaccharide-induced endotoxic shock in mice.

Xiaofeng Niu1, Qingli Mu, Weifeng Li, Huimin Huang, Huan Yao, Huani Li.   

Abstract

Chelerythrine (CHE), a quaternary benzo[c]phenanthridine alkaloid, exhibits a wide spectrum of pharmacological effects. Although CHE has been used to treat various diseases, the protective effects of CHE on lipopolysaccharide (LPS)-induced endotoxic shock have not been explored. The aims of the study were to investigate the protective effects of CHE on LPS-induced endotoxic shock in mice and clarify the mechanism of the effects. We found that pretreatment with CHE (1, 5, and 10 mg/kg, po) at 1 and 12 h before injected intraperitoneally with 1 mg/kg LPS markedly decreased the production of interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α), and myeloperoxidase (MPO) and attenuated the lung histopathological changes. Meanwhile, the effects were dependent on the inhibition of the expression of p65 nuclear factor κB (NF-κB). The protective effects of CHE on LPS-induced endotoxic shock can be attributed to attenuating inflammatory cytokines and inhibition of the expression of NF-κB.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24928629     DOI: 10.1007/s10753-014-9929-7

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  32 in total

1.  Effects of interaction between Escherichia coli verotoxin and lipopolysaccharide on cytokine induction and lethality in mice.

Authors:  Kuri Suzuki; Kazuhiro Tateda; Tetsuya Matsumoto; Fumio Gondaira; Shirou Tsujimoto; Keizo Yamaguchi
Journal:  J Med Microbiol       Date:  2000-10       Impact factor: 2.472

Review 2.  Gram-positive toxic shock syndromes.

Authors:  Emma Lappin; Andrew J Ferguson
Journal:  Lancet Infect Dis       Date:  2009-05       Impact factor: 25.071

3.  Clinical relevance of serum interleukin-6 in Crohn's disease: single point measurements, therapy monitoring, and prediction of clinical relapse.

Authors:  W Reinisch; C Gasché; W Tillinger; J Wyatt; C Lichtenberger; M Willheim; C Dejaco; T Waldhör; S Bakos; H Vogelsang; A Gangl; H Lochs
Journal:  Am J Gastroenterol       Date:  1999-08       Impact factor: 10.864

Review 4.  Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease--radicals or ridiculous?

Authors:  L Kruidenier; H W Verspaget
Journal:  Aliment Pharmacol Ther       Date:  2002-12       Impact factor: 8.171

5.  Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice.

Authors:  M F Neurath; I Fuss; M Pasparakis; L Alexopoulou; S Haralambous; K H Meyer zum Büschenfelde; W Strober; G Kollias
Journal:  Eur J Immunol       Date:  1997-07       Impact factor: 5.532

6.  Simvastatin treatment improves survival in a murine model of burn sepsis: Role of interleukin 6.

Authors:  David C Beffa; Alan J Fischman; Shawn P Fagan; Victoria F Hamrahi; Kasie W Paul; Masao Kaneki; Yong-Ming Yu; Ronald G Tompkins; Edward A Carter
Journal:  Burns       Date:  2010-12-08       Impact factor: 2.744

7.  Expression of tumour necrosis factor-alpha in the rat dental follicle.

Authors:  Gary E Wise; Shaomian Yao
Journal:  Arch Oral Biol       Date:  2003-01       Impact factor: 2.633

Review 8.  Sepsis strategies in development.

Authors:  Steven P LaRosa; Steven M Opal
Journal:  Clin Chest Med       Date:  2008-12       Impact factor: 2.878

9.  Aberrant signaling in the TNFalpha/TNF receptor 1 pathway of the NZM2410 lupus-prone mouse.

Authors:  Kim R M Blenman; Frances R Bahjat; Lyle L Moldawer; Laurence Morel
Journal:  Clin Immunol       Date:  2004-02       Impact factor: 3.969

10.  Tetrandrine ameliorates dextran-sulfate-sodium-induced colitis in mice through inhibition of nuclear factor -kappaB activation.

Authors:  Dei Kui Zhang; Li Na Cheng; Xiao Li Huang; Wei Shi; Jun Ying Xiang; Hua Tian Gan
Journal:  Int J Colorectal Dis       Date:  2008-08-07       Impact factor: 2.571

View more
  5 in total

1.  Chelerythrine Attenuates the Inflammation of Lipopolysaccharide-Induced Acute Lung Inflammation Through NF-κB Signaling Pathway Mediated by Nrf2.

Authors:  Lu Fan; Ye Fan; Li Liu; Weiwei Tao; Xin Shan; Yu Dong; Lin Li; Sen Zhang; Hanqing Wang
Journal:  Front Pharmacol       Date:  2018-09-26       Impact factor: 5.810

2.  Anti-Inflammatory Potentials of the n-Hexane Fraction of Alstonia boonei Stem Bark in Lipopolysaccharide-Induced Inflammation in Wistar Rats.

Authors:  John Oludele Olanlokun; Adeola Oluwakemi Olowofolahan; Olusola Bodede; Adekunle Theophilus Adegbuyi; Gerhard Prinsloo; Paul Steenkamp; Olufunso Olabode Olorunsogo
Journal:  J Inflamm Res       Date:  2021-08-13

3.  Induction of reactive oxygen species-stimulated distinctive autophagy by chelerythrine in non-small cell lung cancer cells.

Authors:  Zheng-Hai Tang; Wen-Xiang Cao; Zhao-Yu Wang; Jia-Hong Lu; Bo Liu; Xiuping Chen; Jin-Jian Lu
Journal:  Redox Biol       Date:  2017-03-09       Impact factor: 11.799

4.  Chelerythrine induced cell death through ROS-dependent ER stress in human prostate cancer cells.

Authors:  Songjiang Wu; Yanying Yang; Feiping Li; Lifu Huang; Zihua Han; Guanfu Wang; Hongyuan Yu; Haiping Li
Journal:  Onco Targets Ther       Date:  2018-05-08       Impact factor: 4.147

5.  Chelerythrine induces apoptosis via ROS-mediated endoplasmic reticulum stress and STAT3 pathways in human renal cell carcinoma.

Authors:  Hongchao He; Ran Zhuo; Jun Dai; Xiaojing Wang; Xin Huang; Haofei Wang; Danfeng Xu
Journal:  J Cell Mol Med       Date:  2019-09-30       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.